Published in Cancer Weekly, September 7th, 2004
The net loss for the second quarter of 2004 was approximately $1.6 million, or $.04 per share, compared with a net loss of approximately $1.1 million, or $.06 per share, in the comparable quarter last year. For the first six months of fiscal 2004, the net loss was approximately $3.0 million, or $.08 per share, compared with a net loss of approximately $2.3 million, or $.12 per share, in the comparable six-month period last year.
Phillip C. Thomas, DOBI Medical's CEO, commented, "The management team continues on plan...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.